H Turnbull1, A Conroy2, R O Opoka3, S Namasopo4, K C Kain5, M Hawkes6. 1. Department of Paediatrics, University of Alberta, Edmonton, Alberta, Canada. 2. Department of Medicine, University of Toronto, Toronto, Ontario, Canada. 3. Department of Paediatrics and Child Health, Mulago Hospital and Makerere University, Kampala, Uganda. 4. Department of Paediatrics, Jinja Regional Referral Hospital, Jinja, Uganda. 5. Department of Paediatrics and Child Health, Mulago Hospital and Makerere University, Kampala, Uganda; Institute of Medical Sciences, University of Toronto, Toronto, Canada; Sandra A Rotman Laboratories, McLaughlin-Rotman Centre for Global Health, Toronto, Canada; McLaughlin Centre for Molecular Medicine, Toronto, Tropical Disease Unit, Toronto General Hospital, Toronto, Ontario, Canada. 6. Department of Paediatrics, University of Alberta, Edmonton, Alberta, School of Public Health, University of Alberta, Edmonton, Canada; Department of Medical Microbiology and Immunology, University of Alberta, Edmonton, Alberta, Canada.
Abstract
SETTING: A resource-limited paediatric hospital in Uganda. OBJECTIVE: Pneumonia is a leading cause of child mortality worldwide. Access to life-saving oxygen therapy is limited in many areas. We designed and implemented a solar-powered oxygen delivery system for the treatment of paediatric pneumonia. DESIGN: Proof-of-concept pilot study. A solar-powered oxygen delivery system was designed and piloted in a cohort of children with hypoxaemic illness. RESULTS: The system consisted of 25 × 80 W photovoltaic solar panels (daily output 7.5 kWh [range 3.8-9.7kWh]), 8 × 220 Ah batteries and a 300 W oxygen concentrator (output up to 5 l/min oxygen at 88% [±2%] purity). A series of 28 patients with hypoxaemia were treated with solar-powered oxygen. Immediate improvement in peripheral blood oxygen saturation was documented (median change +12% [range 5-15%], P < 0.0001). Tachypnoea, tachycardia and composite illness severity score improved over the first 24 h of hospitalisation (P < 0.01 for all comparisons). The case fatality rate was 6/28 (21%). The median recovery times to sit, eat, wean oxygen and hospital discharge were respectively 7.5 h, 9.8 h, 44 h and 4 days. CONCLUSION: Solar energy can be used to concentrate oxygen from ambient air and oxygenate children with respiratory distress and hypoxaemia in a resource-limited setting.
SETTING: A resource-limited paediatric hospital in Uganda. OBJECTIVE:Pneumonia is a leading cause of child mortality worldwide. Access to life-saving oxygen therapy is limited in many areas. We designed and implemented a solar-powered oxygen delivery system for the treatment of paediatric pneumonia. DESIGN: Proof-of-concept pilot study. A solar-powered oxygen delivery system was designed and piloted in a cohort of children with hypoxaemic illness. RESULTS: The system consisted of 25 × 80 W photovoltaic solar panels (daily output 7.5 kWh [range 3.8-9.7kWh]), 8 × 220 Ah batteries and a 300 W oxygen concentrator (output up to 5 l/min oxygen at 88% [±2%] purity). A series of 28 patients with hypoxaemia were treated with solar-powered oxygen. Immediate improvement in peripheral blood oxygen saturation was documented (median change +12% [range 5-15%], P < 0.0001). Tachypnoea, tachycardia and composite illness severity score improved over the first 24 h of hospitalisation (P < 0.01 for all comparisons). The case fatality rate was 6/28 (21%). The median recovery times to sit, eat, wean oxygen and hospital discharge were respectively 7.5 h, 9.8 h, 44 h and 4 days. CONCLUSION: Solar energy can be used to concentrate oxygen from ambient air and oxygenate children with respiratory distress and hypoxaemia in a resource-limited setting.
Authors: Michael T Hawkes; Andrea L Conroy; Sophie Namasopo; Ravi Bhargava; Kevin C Kain; Qaasim Mian; Robert O Opoka Journal: JAMA Pediatr Date: 2018-07-01 Impact factor: 16.193
Authors: Neelima Navuluri; Maria L Srour; Peter S Kussin; David M Murdoch; Neil R MacIntyre; Loretta G Que; Nathan M Thielman; Eric D McCollum Journal: J Glob Health Date: 2021-05-08 Impact factor: 4.413
Authors: Hamish Graham; Shidan Tosif; Amy Gray; Shamim Qazi; Harry Campbell; David Peel; Barbara McPake; Trevor Duke Journal: Bull World Health Organ Date: 2017-02-21 Impact factor: 9.408
Authors: Ryan Calderon; Melissa C Morgan; Mark Kuiper; Harriet Nambuya; Nicholas Wangwe; Akos Somoskovi; Daniel Lieberman Journal: PLoS One Date: 2019-02-06 Impact factor: 3.240
Authors: Nicholas Conradi; Qaasim Mian; Sophie Namasopo; Andrea L Conroy; Laura L Hermann; Charles Olaro; Jackson Amone; Robert O Opoka; Michael T Hawkes Journal: Trials Date: 2019-12-05 Impact factor: 2.279
Authors: Melissa M Medvedev; Victor Tumukunde; Ivan Mambule; Cally J Tann; Peter Waiswa; Ruth R Canter; Christian H Hansen; Elizabeth Ekirapa-Kiracho; Kenneth Katumba; Catherine Pitt; Giulia Greco; Helen Brotherton; Diana Elbourne; Janet Seeley; Moffat Nyirenda; Elizabeth Allen; Joy E Lawn Journal: Trials Date: 2020-01-31 Impact factor: 2.279
Authors: Yiming Huang; Qaasim Mian; Nicholas Conradi; Robert O Opoka; Andrea L Conroy; Sophie Namasopo; Michael T Hawkes Journal: JAMA Netw Open Date: 2021-06-01